Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Lobectomy vs. total thyroidectomy in papillary thyroid cancer with intermediate risk].

Chirurgie (Heidelberg, Germany)·2026
Same author

Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database.

Journal of neuroendocrinology·2026
Same author

[Is intraoperative parathyroid hormone measurement necessary in cases of primary hyperparathyroidism when preoperative imaging results are consistent?]

Chirurgie (Heidelberg, Germany)·2026
Same author

Chirurgie (Heidelberg, Germany)·2026
Same author

[Gastric neuroendocrine neoplasms: update on endoscopic and surgical management].

Chirurgie (Heidelberg, Germany)·2026
Same author

[Current diagnostics and treatment of adrenal tumors].

Chirurgie (Heidelberg, Germany)·2026

Related Experiment Video

Updated: May 13, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Familial pancreatic cancer: current status.

Peter Langer1, Emily Slater, Volker Fendrich

  • 1Philipps-University Hospital, Department of General Surgery, Baldingerstraße, D-35043 Marburg, Germany +49 6421 2866442 ; +49 6421 2868995 langerp@mailer.uni-marburg.de.

Expert Opinion on Medical Diagnostics
|March 16, 2013
PubMed
Summary

Familial pancreatic cancer (FPC) affects families with multiple affected relatives. Screening high-risk individuals using endoscopic ultrasound can detect precursor lesions, though false positives occur.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Experiment Videos

Last Updated: May 13, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Area of Science:

  • Oncology
  • Genetics
  • Gastroenterology

Background:

  • Familial pancreatic cancer (FPC) is defined by multiple affected first-degree relatives.
  • It represents an inherited tumor syndrome, often autosomal dominant, with varied presentation.
  • Known inherited cancer syndromes are excluded in the FPC definition.

Purpose of the Study:

  • To summarize the understanding of familial pancreatic cancer.
  • To highlight the importance of screening high-risk individuals.
  • To discuss current screening modalities and their outcomes.

Main Methods:

  • Review of existing literature and definitions of FPC.
  • Discussion of genetic factors, including BRCA2 mutations.
  • Analysis of screening program data using endoscopic ultrasound.

Main Results:

  • FPC families have a higher risk of pancreatic cancer.
  • Genetic defects are not fully identified in most FPC cases.
  • Prospective screening identified precursor lesions but also false positives.

Conclusions:

  • FPC is a significant inherited risk for pancreatic cancer.
  • Screening high-risk individuals is recommended.
  • Endoscopic ultrasound shows promise but requires careful interpretation due to false positives.